Press Releases

Notice of Cipher Pharmaceuticals Q1 2018 Conference Call & Annual Meeting

MISSISSAUGA, ON, May 1, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q1 2018 financial results conference call and Annual and Special Meeting of shareholders on Thursday, May 10, 2018.


WHEN: Thursday, May 10, 2018 at 8:30AM ET

CONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through or An archived replay of the webcast will be available for 90 days.


WHEN: Thursday, May 10, 2018 at 11:00AM ET

WHERE: Wildeboer Dellelce LLP, Wildeboer Dellelce Place, 365 Bay Street, Suite 800, Toronto, ON

About Cipher Pharmaceuticals Inc.
Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. Cipher is focused on a three-pronged growth strategy – including acquisitions, in-licensing, and selective investments in drug development – to assemble a broad portfolio of prescription products that serve unmet medical needs. For more information, visit

SOURCE Cipher Pharmaceuticals Inc.

For further information: Craig Armitage, LodeRock Advisors, (416) 347-8954,